A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

October 17, 2022

Study Completion Date

October 17, 2022

Conditions
Temple Hollowing
Interventions
DEVICE

JUVÉDERM® VOLUMA® XC

JUVÉDERM® VOLUMA® XC injectable gel

OTHER

No-treatment control

Participants received no treatment for 3 months during the Control Period.

Trial Locations (15)

12110

Williams Plastic Surgery Specialists /ID# 232789, Latham

33134

Hevia Cosmetic Dermatology /ID# 232824, Coral Gables

33431

Steven Fagien MD PA /ID# 232807, Boca Raton

34209

Bradenton Dermatologist /ID# 232822, Bradenton

37203

The Practice of Brian S. Biesman MD PLLC /ID# 232662, Nashville

70115

Delricht Research /ID# 233142, New Orleans

75231

Dallas Plastic Surgery Institute /ID# 232971, Dallas

90069

Skin Care and Laser Physicians of Beverly Hills /ID# 232967, Los Angeles

92663

Steve Yoelin MD Medical Associate Inc /ID# 232956, Newport Beach

33137-3254

Skin and Cancer Associates, LLP /ID# 232923, Miami

33401-2712

Research Institute of the Southeast, LLC /ID# 233144, West Palm Beach

20769-9182

Callender Center for Clinical Research /ID# 233167, Glenn Dale

02467

Skincare Physicians /ID# 233054, Chestnut Hill

27517-9901

Aesthetic Solutions /ID# 232953, Chapel Hill

00917

Jose Raul Montes Eyes & Facial Rejuvenation-Torre Medica Aux /ID# 232706, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY